Healthcare
Live Price
Offline$5.45
+0.00% today
1Y Change
+12.37%
Window
Jun 26, 2025 → Jun 23, 2026
Coverage: 248 bars · Jun 26, 2025 → Jun 23, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Bumrungrad Hospital Public Company Limited (BUHPF) is a Healthcare stock with a market cap of $142.30B. The stock last traded around $5.45 and up 12.4% across the available one-year price window (Jun 26, 2025 → Jun 23, 2026). Baseline metrics include revenue growth of -2.3%, EPS growth of -3.3%, a dividend yield of 6.1%. What stands out right now is revenue -2.3%, EPS -3.3%, free cash flow -10.3% with operating margin 34.9% and ROIC 20.9%. The dividend matters to the case here, with a current yield around 6.1%. Valuation sits in the middle of the pack at P/E 18.8 and price/sales 5.6. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines BUHPF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
BUHPF
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
BUHPF Max Drawdown
-3.54%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for BUHPF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$12.5B
-39.9% YoY
FY Net Income
$1.2B
-75.4% YoY
Free Cash Flow
$2.6B
-48.2% YoY
Revenue Growth
-2.3%
EPS Growth
-3.3%
Gross Margin
52.0%
Net Margin
30.0%
Income statement
THB
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 25.1B | 25.7B | 25.4B | 20.7B | 12.5B |
| Gross Profit | 12.7B | 13.2B | 12.5B | 9.6B | 4.7B |
| Operating Income | 8.8B | 9.2B | 8.5B | 6.0B | 1.5B |
| EBITDA | 9.8B | 10.5B | 9.7B | 7.2B | 2.8B |
| Net Income | 7.5B | 7.8B | 7.0B | 4.9B | 1.2B |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
THB
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 7.6B | 3.3B | 3.8B | 2.1B | 1.8B |
| Total Assets | 36.4B | 32.7B | 29.2B | 24.3B | 20.9B |
| Total Liabilities | 5.6B | 4.9B | 5.1B | 4.3B | 3.2B |
| Shareholder Equity | 30.5B | 27.5B | 23.8B | 19.7B | 17.3B |
| Total Debt | 487M | 139M | 91M | 63M | 94M |
| Net Debt | -7.1B | -3.1B | -3.7B | -2.0B | -1.7B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
3.6B
-42.8% YoY
Capital Expenditures
969M
+20.6% YoY
Free Cash Flow
2.6B
-48.2% YoY
Key ratios
Gross Margin
52.0%
Operating Margin
34.9%
Net Margin
30.0%
ROE
25.1%
Debt / Equity
0.01x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.